top of page

Immune Function

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Δ9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo.

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations.

Immunoactive effects of cannabinoids: Considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

​Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.

Inflammation

Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells

Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation

Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis

Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study

Cannabinoid-based drugs as anti-inflammatory therapeutics

Cannabinoid CB2 receptors in human brain inflammation

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?

Cannabinoids as novel anti-inflammatory drugs

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

Cannabinoids, inflammation, and fibrosis

Cannabinoids in models of chronic inflammatory conditions

Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability

Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells

Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation

Clinical Implications for Cannabinoid Use in the Rheumatic Diseases

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders

Ischemia

Activation of Cannabinoid CB2 ReceptoreMediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion

Cannabidiol administration after hypoxiaeischemia to newborn rats reduces
long-term brain injury and restores neurobehavioral function

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia

HU-211, a Novel Noncompetitive N-Methyl-d-Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat

Mechanisms of cannabidiol neuroprotection in hypoxiceischemic newborn pigs:
Role of 5HT1A and CB2 receptors

The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

Update on the Role of Cannabinoid Receptors after Ischemic Stroke

bottom of page